Literature DB >> 10189887

Apoptotic changes precede mitochondrial dysfunction in red cell-type pyruvate kinase mutant mouse erythroleukemia cell lines.

K Aisaki1, H Kanno, N Oyaizu, Y Hara, S Miwa, Y Ikawa.   

Abstract

Two erythroleukemia cell lines have been established from the splenic lesions of red blood cell-type pyruvate kinase (R-PK) activity-deficient mice of CBA/N origin infected with a polycythemic strain of Friend leukemia virus complex (FVp). Ten to 30% of the cells of these cell lines undergo apoptotic changes in routine passage, as shown by nuclear fragmentation, DNA laddering, DNA content (propidium iodide (PI) staining), and annexin V binding assay. In these cells, however, although adenosine 5'-triphosphate (ATP) levels were lower than in the control cells, the mitochondrial inner transmembrane potential (delta psi m), detected by rhodamine 123 (R123) and diSC3(5) staining, remained unchanged until the final stage of apoptosis. No evidence was obtained to relate this finding to R-PK mutation due to difficulty in cloning stable, conditionally inducible R-PK gene transfectants. However, low delta psi m in the apoptotic cell population of the control T3-K-1 (K-1) and T3-CI-2-0 (2-0) Friend erythroleukemia cells supports a possible relationship, as do results obtained in two Friend erythroleukemia cells recently isolated from normal CBA/N mice. These cell lines are expected to be useful for clarifying both the primary apoptotic changes independent of mitochondrial dysfunction and the PK-isozyme changes during erythrodifferentiation, for example, the decreased muscle type 2 (M2) PK level. Modification of growth signals in these cell lines may modulate differentiation and/or apoptosis and allow further elucidation of the signaling networks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10189887      PMCID: PMC5926040          DOI: 10.1111/j.1349-7006.1999.tb00730.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells.

Authors:  H Kanno; H Fujii; S Miwa
Journal:  Biochem Biophys Res Commun       Date:  1992-10-30       Impact factor: 3.575

2.  Delayed onset of hemolytic anemia in CBA-Pk-1slc/Pk-1slc mice with a point mutation of the gene encoding red blood cell type pyruvate kinase.

Authors:  K Tsujino; H Kanno; K Hashimoto; H Fujii; T Jippo; E Morii; Y M Lee; H Asai; S Miwa; Y Kitamura
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

3.  The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters.

Authors:  T Noguchi; K Yamada; H Inoue; T Matsuda; T Tanaka
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

4.  Electrophoretic and kinetic studies of mutant erythrocyte pyruvate kinases.

Authors:  K Nakashima; S Miwa; S Oda; T Tanaka; K Imamura
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

5.  Studies on pyruvate kinase (PK) deficiency. II. Electrophoretic, kinetic and immunological studies on pyruvate kinase of erythrocytes and other tissues.

Authors:  K Imamura; T Tanaka; T Nishina; K Nakashima; S Miwa
Journal:  J Biochem       Date:  1973-12       Impact factor: 3.387

Review 6.  Concise review: pyruvate kinase deficiency: historical perspective and recent progress of molecular genetics.

Authors:  S Miwa; H Kanno; H Fujii
Journal:  Am J Hematol       Date:  1993-01       Impact factor: 10.047

7.  Induction of 2,3-bisphosphoglycerate synthase in Friend leukemia cells.

Authors:  H Narita; S Yanagawa; R Sasaki; H Chiba
Journal:  Biochem Biophys Res Commun       Date:  1981-11-16       Impact factor: 3.575

8.  Intracellular ATP levels determine cell death fate by apoptosis or necrosis.

Authors:  Y Eguchi; S Shimizu; Y Tsujimoto
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

9.  Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain.

Authors:  H Kanno; M Morimoto; H Fujii; T Tsujimura; H Asai; T Noguchi; Y Kitamura; S Miwa
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

10.  Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation.

Authors:  M Morimoto; H Kanno; H Asai; T Tsujimura; H Fujii; Y Moriyama; T Kasugai; A Hirono; Y Ohba; S Miwa; Y Kitamura
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

View more
  1 in total

1.  Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.

Authors:  Bo Zhang; Jian-Ying Chen; Dao-Da Chen; Guo-Bin Wang; Ping Shen
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.